[{"Assets_0_Q3_USD":"43010400000.0","CIK":"59478","CommonStockDividendsPerShareCashPaid_1_Q3_USD":"0.52","CommonStockDividendsPerShareCashPaid_3_Q3_USD":"1.56","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"0.53","EarningsPerShareBasic_3_Q3_USD":"1.38","EarningsPerShareDiluted_1_Q3_USD":"0.53","EarningsPerShareDiluted_3_Q3_USD":"1.37","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"282857000000.0","MinorityInterest_0_Q3_USD":"70300000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"3872100000.0","NetIncomeLoss_1_Q3_USD":"555600000.0","NetIncomeLoss_3_Q3_USD":"1452800000.0","OfficialName":"Eli Lilly and Company Common Stock","PaymentsOfDividends_3_Q3_USD":"1643800000.0","RevenuesConverted_1_Q3_USD":"5658000000.0","RevenuesConverted_3_Q3_USD":"16710600000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":"14960600000.0","StockholdersEquity_0_Q3_USD":"14890300000.0","Ticker":"LLY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"1056000000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"1057000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"1053400000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"1054800000.0","filed":"20171027","footnote":null,"form":"10-Q","fp":"Q3","fy":"2017.0","name":"LILLY ELI & CO","period":"20170930","qtrs":"0","uom":"USD"}]